Profile banner
Kimberly Negrin, Ph.D.

Kimberly Negrin, Ph.D.

Commercialization leader in cell & gene therapy and biotech advisor

Summary

Commercialization and go-to-market leadership for cell and gene therapies: Kimberly has repeatedly held commercial and business-development roles (from Seahorse product specialist to senior commercial leadership at Nucleus Biologics and business unit leadership at Stoic Bio), focusing on translating scientific innovations into scalable, GMP-compatible processes and customer-facing solutions. nucleusbiologics+2
Expertise in cell therapy supply chains and donor strategies: Through roles at HemaCare/Charles River and webinar presentations, she has focused on donor sourcing, dedicated donor pools, and strategies to improve starting material consistency for commercialization. criver+2
Founder and advisor blending science with strategic advisory: As founder of Bloom Bio and a strategic/advisory board member across early-stage companies and accelerators, she provides fractional leadership, commercialization strategy, and executive coaching to life-science founders and underserved entrepreneurs. timexcapital+2
Focus on sustainable and practical innovations in cell culture: Her work with Stoic Bio and Nucleus Biologics emphasizes sustainable media solutions (e.g., powdered media pods) and custom GMP media to improve process efficiency and reduce environmental impact. stoicbio+1

Work

Education

Projects